/
NEWG
$0.00+$0.00 (+900.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
9% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $622 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | −$622 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$7.3K | −$24.1K | −$40.8K | −$43.0K | −$33.4K | −$41.9K |
| EBITDA | −$6.7K | −$22.9K | −$40.3K | −$43.0K | −$33.4K | −$41.9K |
| Net income | −$7.3K | −$24.1K | −$40.8K | −$43.0K | −$33.4K | −$41.9K |
| Net margin | — | — | — | — | — | — |
| EPS (diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
Peer comparison
NEWGEN BIOPHARMA CORP
NEWGEN BIOPHARMA CORP
Held by traders on TradeandTell
No one on the platform currently holds NEWG.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NEWG as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded NEWG yet.